title: [Gene polymorphisms and pharmacogenetics in Rheumatoid Arthritis].
abstract: Rheumatoid arthritis (RA) is a systemic, chronic and inflammatory disease of unknown aetiology with a genetic predisposition. The advent of new biological agents, as well as the more traditional disease-modifying anti rheumatic drugs, has resulted in highly efficient therapies for reducing the symptoms and signs of RA; however, not all patients show the same level of response regarding disease progression to these therapies. These variations suggest that RA patients may have different genetic regulatory mechanisms. The extensive polymorphisms revealed in non-coding gene-regulatory regions in the immune system, as well as genetic variations in drug-metabolizing enzymes, suggest that this type of variation is of functional and evolutionary importance and may provide clues for developing new therapeutic strategies. Pharmacogenetics is a rapidly advancing area of research that holds the promise that therapies will soon be tailored to an individual patient's genetic profile.
authors.affiliation: Unidad de Investigación del Envejecimiento Osteoarticular, Laboratorio de Investigación, Unidad de Genómica, INIBIC, División de Reumatología, A Coruña, España.
authors.forename: Ignacio
authors.initials: I
authors.lastname: Rego-Pérez
authors.forename: Mercedes
authors.initials: M
authors.lastname: Fernández-Moreno
authors.forename: Vanessa
authors.initials: V
authors.lastname: Carreira-García
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: Blanco